Other OTC Pharmaceuticals (Pharmacies) - Jordan

  • Jordan
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$31.04m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.34%, resulting in a market volume of US$33.17m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.73 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Jordan has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to the development of this market. Customer preferences in Jordan have shifted towards self-medication and the use of over-the-counter (OTC) pharmaceuticals. This can be attributed to several factors, including the convenience and accessibility of OTC products in pharmacies. Customers are increasingly seeking quick and easy solutions for minor health issues, and OTC pharmaceuticals provide them with the ability to address these concerns without the need for a prescription. Additionally, the rising cost of healthcare services has also led customers to opt for OTC products as a more affordable alternative. Trends in the market have further driven the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Jordan. One notable trend is the increasing availability of a wide range of OTC products in pharmacies. Pharmacies have expanded their product offerings to include various OTC medications, such as pain relievers, cough and cold remedies, and digestive aids. This trend has been driven by the demand from customers and the desire of pharmacies to cater to their needs. Furthermore, the growing awareness of preventive healthcare has also contributed to the demand for OTC pharmaceuticals in Jordan. Local special circumstances in Jordan have played a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a well-established healthcare system, with a large number of pharmacies spread across the country. This extensive network of pharmacies ensures that OTC pharmaceuticals are easily accessible to customers, regardless of their location. Additionally, the government has implemented regulations to ensure the quality and safety of OTC products, further boosting customer confidence in purchasing these medications from pharmacies. Underlying macroeconomic factors have also influenced the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Jordan. The country has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. This has allowed customers to allocate a larger portion of their budget towards healthcare expenses, including the purchase of OTC pharmaceuticals. Furthermore, the government's focus on improving healthcare infrastructure and services has also contributed to the growth of the market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Jordan has been developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the increasing availability of OTC products in pharmacies, the well-established healthcare system, and the country's economic growth have all contributed to the growth of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)